The markets opened higher with the Dow gaining 30 points to 16,951 as investors continued to monitor developments in Iraq. Nasdaq eased 2 points to 4,356.
On the upside
CarMax (NYSE: KMX) reported higher first quarter earnings and revenue that beat analyst expectations.
StemCells (Nasdaq: STEM) closed enrollment in its Phase I/II clinical trial for dry age-related macular degeneration.
Shire (Nasdaq: SHPG) rejected a $46.2 billion acquisition offer from AbbVie (NYSE: ABBV).
On the downside
Fourth quarter earnings and revenue topped analyst estimates for Smith & Wesson (Nasdaq: SWHC) but the firearms maker forecast current quarter and full year earnings below expectations.
Hercules Offshore (Nasdaq: HERO) released its June Fleet Status Report.
Shares of RadioShack (NYSE: RSH) continued falling.
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 3 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 added 2 points to 1961. Bitcoin eased $1.13 or 0.19% to $591.24.
